We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

IN RE: BLOOD REAGENTS ANTITRUST LITIGATION

  1. July 13, 2018

    Ortho's $19.5M Deal Ending Antitrust MDL Gets Initial OK

    A Pennsylvania federal judge on Thursday greenlighted Ortho-Clinical Diagnostics Inc.'s $19.5 million deal to resolve allegations in multidistrict litigation that the former Johnson & Johnson unit conspired with another company to fix prices on the reagents used in blood tests.

  2. October 19, 2015

    Purchasers Win Cert. Again In Blood Test Antitrust MDL

    A Pennsylvania federal judge on Monday recertified a class of buyers of reagents used in blood tests in multidistrict litigation alleging that a former Johnson & Johnson unit conspired with another company to fix prices on the reagents.

  3. August 23, 2012

    Purchaser Class Certified In J&J Blood Test Antitrust MDL

    A Pennsylvania federal judge on Wednesday said buyers of reagents used in blood tests had satisfied the requirements to certify a class in an action alleging that a Johnson & Johnson unit conspired with another company to fix prices on the reagents.

  4. March 5, 2012

    Immucor To Pay $22M To Stanch Blood Test Antitrust Action

    Immucor Inc. has agreed to pay $22 million to resolve its part in a class action alleging it conspired with a Johnson & Johnson unit to fix prices of blood-testing reagents, according to a settlement agreement granted preliminary approval Monday.